Organon & Co [NYSE: OGN] closed the trading session at $9.63 on 2025-07-16.
The stocks have a year to date performance of -54.79 percent and weekly performance of -2.83 percent. The stock has been moved at -38.51 percent over the last six months. The stock has performed -4.08 percent around the most recent 30 days and changed -14.78 percent over the most recent 3-months.
If compared to the average trading volume of 5.65M shares, OGN reached to a volume of 3360813 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Organon & Co [OGN]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for OGN shares is $13.33 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on OGN stock is a recommendation set at 3.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Evercore ISI have made an estimate for Organon & Co shares, keeping their opinion on the stock as In-line, with their previous recommendation back on May 02, 2025. While these analysts kept the previous recommendation, JP Morgan raised their target price from $18 to $20. The new note on the price target was released on September 06, 2024, representing the official price target for Organon & Co stock. Previously, the target price had yet another drop from $33 to $16, while Goldman kept a Neutral rating on OGN stock.
The Price to Book ratio for the last quarter was 4.58, with the Price to Cash per share for the same quarter was set at 2.10. Price to Free Cash Flow for OGN in the course of the last twelve months was 3.22 with Quick ratio for the last quarter at 1.15.
OGN stock trade performance evaluation
Organon & Co [OGN] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -2.83. With this latest performance, OGN shares dropped by -4.08% in over the last four-week period, additionally sinking by -38.51% over the last 6 months – not to mention a drop of -35.46% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for OGN stock in for the last two-week period is set at 45.24, with the RSI for the last a single of trading hit 0.35, and the three-weeks RSI is set at 0.41 for Organon & Co [OGN]. The present Moving Average for the last 50 days of trading for this stock 9.45, while it was recorded at 9.79 for the last single week of trading, and 13.86 for the last 200 days.
Organon & Co [OGN]: An insightful look at the core fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Organon & Co [OGN] shares currently have an operating margin of 22.32% and a Gross Margin at 57.18%. Organon & Co’s Net Margin is presently recorded at 11.92%.
Return on Equity for this stock inclined to 5.99%, with Return on Assets sitting at 5.99%. When it comes to the capital structure of this company, Organon & Co [OGN] has a Total Debt to Total Equity ratio set at 16.52.
Reflecting on the efficiency of the workforce at the company, Organon & Co [OGN] managed to generate an average of $75000.0 per employee.Organon & Co’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.15 and a Current Ratio set at 1.67.
Earnings per share (EPS) analysis for Organon & Co [OGN] stock
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for OGN. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Organon & Co go to 1.35%.
Organon & Co [OGN]: Institutional Ownership
The top three institutional holders of OGN stocks are: BLACKROCK INC. with ownership of 32.58 million shares, which is approximately 12.6625%. VANGUARD GROUP INC, holding 30.21 million shares of the stock with an approximate value of $$625.41 million in OGN stocks shares; and VANGUARD GROUP INC, currently with $$208.88 million in OGN stock with ownership which is approximately 3.922%.
